Company Filing History:
Years Active: 1981-1983
Title: The Innovations of Ronald D. Schoenwald
Introduction
Ronald D. Schoenwald is a notable inventor based in Fort Worth, TX (US). He has made significant contributions to the field of ophthalmology through his innovative inventions. With a total of 2 patents, Schoenwald has focused on developing advanced drug delivery systems for ophthalmic applications.
Latest Patents
Schoenwald's latest patents include a groundbreaking invention related to sustained release ophthalmic drug dosage. This invention is directed to an aqueous dispersion of an ophthalmic drug combined with a high molecular weight polymer. The resulting composition forms a highly viscous gel that prolongs the duration of activity of the ophthalmic drug when applied into the conjunctival sac of the eye. The gel composition has a prolonged retention time in the eye, ensuring that it remains in contact with the surface for an extended period.
Career Highlights
Throughout his career, Ronald D. Schoenwald has been associated with Alcon Laboratories, Inc., a leading company in the field of eye care. His work has contributed to advancements in ophthalmic drug formulations, enhancing the effectiveness of treatments for various eye conditions.
Collaborations
Schoenwald has collaborated with fellow inventor Robert E. Roehrs, furthering the development of innovative solutions in ophthalmology.
Conclusion
Ronald D. Schoenwald's contributions to ophthalmic drug delivery systems highlight his commitment to improving patient care. His inventions continue to influence the field and pave the way for future advancements in eye treatment.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.